rheumatology
Scleroderma

More effort urged on steroid-sparing approach to lupus

Rheumatologists have been urged to avoid complacency with regards to the long-term use of glucocorticoids in systemic lupus erythematosus. Up to 80% of lupus patients are exposed to glucocorticoids despite increasing evidence of their risks, according to a review published recently in Rheumatology.  Co-author Dr Diane Apostolopoulos, from the School of Clinical Sciences at Monash ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic